Dynatrace
DT
$40.61
+0.52%
Dynatrace, Inc. is a leading software-as-a-service (SaaS) company operating in the Technology sector, specifically within the Software - Application industry. It provides a unified platform for monitoring and analyzing IT infrastructure, enabling clients to optimize performance and ensure uptime by ingesting and analyzing machine-generated data in real-time. The company is a recognized leader in the application performance monitoring and observability space, distinguished by its AI-powered automation and comprehensive, all-in-one platform approach. The current investor narrative is dominated by a stark contrast between its strong profitability and a perceived growth deceleration, as recent quarterly results were overshadowed by guidance signaling a slowdown, leading to significant stock volatility and a widening valuation gap against faster-growing peers like Datadog.…
DT
Dynatrace
$40.61
Related headlines
Investment Opinion: Should I buy DT Today?
Rating: Hold. The core thesis is that Dynatrace is a fundamentally strong company caught in a painful growth deceleration narrative; the severe price correction has removed much of the overvaluation, but catalysts for a re-rating are not yet visible.
Supporting Evidence: The stock trades at a forward P/E of 18.3x, which is reasonable for a profitable software company, especially one with gross margins above 81%. Revenue growth remains solid at 18.18% YoY, and the company generates robust free cash flow of $465.7M TTM. However, the 1-year price decline of -25.57% and massive underperformance versus the market (-50.6% relative strength) reflect the powerful negative sentiment. The valuation has compressed from historical trailing P/E highs above 90x to the current 67.6x, indicating a significant reset.
Risks & Conditions: The two biggest risks are 1) further growth deceleration below 15%, and 2) a failure to expand net margins from the current 7.8%. This Hold rating would upgrade to a Buy if the forward P/E compresses below 16x on sustained fears, or if the company demonstrates a re-acceleration of revenue growth above 20% in upcoming quarters. It would downgrade to a Sell if revenue growth decelerates to low-double digits or if the stock breaks below its 52-week low of $31.64 on deteriorating fundamentals. Relative to its own history and the growth/profitability trade-off, the stock is moving towards fair value but remains slightly overvalued until growth stabilizes.
Sign up to view all
DT 12-Month Price Forecast
Dynatrace presents a conflicted picture: superb profitability and financial health versus a clear growth slowdown that the market is punishing. The neutral stance reflects the view that the sharp correction has balanced the risk/reward, but catalysts for outperformance are not yet evident. The forward P/E of 18.3x is not demanding if the company can meet its ~$2.98 EPS estimate, providing a floor. However, the stock needs to demonstrate growth stabilization to attract renewed interest. The stance would upgrade to bullish on evidence of sustained margin expansion or growth re-acceleration above 20%. It would turn bearish if the stock breaks below $31.64, signaling a failure of the current valuation support.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Dynatrace's 12-month outlook, with a consensus price target around $52.79 and implied upside of +30.0% versus the current price.
Average Target
$52.79
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$32 - $53
Analyst target range
Analyst coverage for Dynatrace appears limited in the provided dataset, with only 4 analysts cited for estimates, which is insufficient to derive a robust consensus recommendation or target price distribution. The lack of a comprehensive consensus, average target price, or clear Buy/Hold/Sell breakdown in the data suggests institutional coverage may be deeper than shown, but based on the provided inputs, we must state that insufficient analyst coverage data is available for a detailed consensus analysis. This limited visible coverage could imply the stock, despite its $11 billion market cap, may have less mainstream institutional following than larger peers, potentially leading to higher volatility and less efficient price discovery as it trades more on its own fundamentals and news flow rather than analyst herd behavior. The recent institutional ratings from February 2026 show a series of reiterations from major firms including Barclays (Overweight), Wells Fargo (Overweight), and UBS (Neutral), indicating stability in analyst views post-earnings, but without quantified targets, the signal strength and implied upside cannot be calculated from the given data.
Bulls vs Bears: DT Investment Factors
The evidence currently tilts bearish, as the market's punitive reaction to growth deceleration guidance has been severe and persistent, outweighing the company's strong profitability. The bear case is supported by a clear negative narrative shift, significant underperformance, and a widening competitive valuation gap. However, the bull case is grounded in tangible financial strength, a reset valuation, and signs of technical stabilization. The single most important tension in the investment debate is whether Dynatrace's industry-leading profitability and cash generation can eventually outweigh the market's overwhelming focus on top-line growth deceleration relative to peers. The resolution of this tension—through either a re-acceleration of growth or a market re-rating towards profitable scale—will determine the stock's direction.
Bullish
- Exceptionally Strong Profitability & Cash Flow: Dynatrace maintains industry-leading gross margins of 81.41% and generates substantial free cash flow of $465.7M TTM, providing a robust financial foundation. This profitability enables internal funding of growth and operations, as evidenced by a minimal debt-to-equity ratio of 0.063, insulating the company from interest rate risk.
- Attractive Forward Valuation After Sell-off: The stock's forward P/E of 18.3x is reasonable for a profitable SaaS company and represents a significant discount from its trailing P/E of 67.6x, implying the market expects strong earnings growth. This multiple has compressed from historical highs above 90x, suggesting much of the growth deceleration fear is already priced in.
- Solid Revenue Growth Despite Deceleration: Q3 2026 revenue grew 18.18% year-over-year to $515.5M, demonstrating the core business remains healthy. While growth is moderating sequentially, the absolute level is still robust for a company of its scale and profitability profile.
- Technical Stabilization After Severe Drawdown: The stock is up 8.86% over the last 3 months and is trading 28% above its 52-week low of $31.64, suggesting a potential bottoming process after a -42.87% maximum drawdown. This recent stabilization, coupled with a low beta of 0.74, indicates reduced volatility and potential for a value-driven recovery.
Bearish
- Clear Growth Deceleration Narrative: Recent news highlights that strong quarterly results were overshadowed by guidance signaling a significant slowdown, causing a sharp sell-off. The sequential revenue trend from Q1 ($477.3M) to Q3 ($515.5M) shows moderating growth, validating market concerns about future momentum.
- Valuation Gap vs. Faster-Growing Peers: The market is heavily favoring competitors like Datadog for their accelerating growth, creating a stark valuation gap. Dynatrace's trailing P/E of 67.6x remains elevated despite the sell-off, and it must demonstrate it can close this growth perception gap to justify a premium.
- Persistent Long-Term Underperformance: The stock has underperformed the S&P 500 by over 50 percentage points in the last year (-25.57% vs. SPY +24.99%). This profound underperformance, despite strong fundamentals, reflects a loss of investor confidence and a sector rotation away from perceived slower-growth SaaS names.
- Limited Analyst Coverage & Visibility: Only 4 analysts are cited in the data, indicating potentially less institutional following and less efficient price discovery. The lack of a robust consensus target price increases uncertainty and reliance on company-specific news flow, which has recently been negative.
DT Technical Analysis
The stock is entrenched in a pronounced long-term downtrend, evidenced by a 1-year price change of -25.57%, significantly underperforming the broader market. With a current price of $41.42, it is trading near the lower end of its 52-week range, approximately 28% above its 52-week low of $31.64 but 28% below its 52-week high of $57.55; this positioning suggests the stock is in a deep correction phase, presenting a potential value opportunity but also reflecting significant fundamental concerns. Recent momentum shows signs of stabilization and modest recovery, with a 3-month gain of 8.86% and a 1-month gain of 3.65%, indicating a potential attempt to find a bottom after the severe drawdown. However, this short-term uptick conflicts with the persistent negative longer-term trend, and the stock's beta of 0.74 indicates it has been 26% less volatile than the market, which is unusual for a growth software name and may signal a loss of speculative interest. Key technical support is anchored at the 52-week low of $31.64, while resistance looms at the 52-week high of $57.55; a sustained breakdown below $31.64 would signal a new leg down, whereas a decisive move above the recent recovery highs near $45 could suggest the downtrend is abating. The stock's maximum drawdown of -42.87% underscores the severe bearish pressure it has endured, and its low beta relative to the SPY's strong 1-year gain of 24.99% highlights its profound underperformance and defensive trading behavior.
Beta
0.74
0.74x market volatility
Max Drawdown
-42.9%
Largest decline past year
52-Week Range
$32-$58
Price range past year
Annual Return
-27.2%
Cumulative gain past year
| Period | DT Return | S&P 500 |
|---|---|---|
| 1m | -1.5% | -1.7% |
| 3m | +8.7% | +13.7% |
| 6m | -8.4% | +6.2% |
| 1y | -27.2% | +20.8% |
| ytd | -4.1% | +7.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DT Fundamental Analysis
Revenue growth remains robust but shows signs of sequential deceleration; the most recent quarterly revenue for Q3 2026 was $515.47 million, representing a solid year-over-year growth rate of 18.18%. However, examining the multi-quarter trend reveals revenue of $493.85 million in Q2 and $477.35 million in Q1, indicating growth is still positive but the pace from Q1 to Q3 has moderated, which aligns with market concerns about future growth slowdowns cited in recent news. The company is solidly profitable with a net income of $40.06 million in the last quarter and maintains industry-leading gross margins of 81.41%, though the net margin of 7.77% reflects significant operating expenses; profitability has been consistent, with net income of $57.24 million and $47.96 million in the prior two quarters, demonstrating the company's ability to generate earnings despite growth investments. The balance sheet is exceptionally strong with minimal financial risk, evidenced by a very low debt-to-equity ratio of 0.063 and a healthy current ratio of 1.35, providing ample liquidity. The company generates substantial cash, with free cash flow over the trailing twelve months of $465.73 million, and an ROE of 6.23%, indicating it can fund operations and growth internally without reliance on external financing, which is a key pillar of financial stability.
Quarterly Revenue
$515473000.0B
2025-12
Revenue YoY Growth
+0.18%
YoY Comparison
Gross Margin
+0.81%
Latest Quarter
Free Cash Flow
$465728999.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DT Overvalued?
Given the company's consistent profitability with a positive net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE ratio is elevated at 67.64x, while the forward PE is significantly lower at 18.31x; this substantial gap implies the market is pricing in a sharp acceleration in earnings growth over the next year, likely driven by expectations of margin expansion and continued revenue scaling. Compared to typical software industry averages, a trailing PE of 67.64x would represent a significant premium; however, the forward multiple of 18.31x appears more reasonable, suggesting the current premium is based on future earnings potential rather than current results. Historically, the stock's own valuation has compressed dramatically; its current trailing PE of 67.64x is below the historical highs seen in recent quarters (e.g., 81.46x in Q3 2026 and over 90x in 2024) but remains above the lows from its earlier history as a public company. This positioning in the mid-to-lower end of its own historical band suggests the market has already priced out much of the previous optimism, but the stock is not yet at deep value levels, indicating expectations are resetting to a more moderate growth profile.
PE
68.5x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 11x~3616x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
31.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is not leverage or liquidity—the balance sheet is pristine with minimal debt—but rather earnings volatility and margin pressure. The net margin of 7.77% is modest given the 81.4% gross margin, indicating high operating expenses that could compress further if revenue growth slows. The trailing P/E of 67.6x, while down from highs, still embeds high growth expectations; any further deceleration or earnings miss would trigger significant multiple compression. The company's valuation is dependent on maintaining its premium gross margins while scaling profitability, a challenging balance in a competitive market.
Market & Competitive Risks: The stock faces acute competitive and valuation risks. The market narrative, as highlighted in recent news, starkly favors faster-growing peers like Datadog, creating a perception gap that is difficult to close. Trading at a forward P/E of 18.3x, while more reasonable, still requires the company to hit aggressive forward earnings estimates to justify the price. The stock's low beta of 0.74, unusual for SaaS, signals it has lost its 'growth stock' status and may be vulnerable to further de-rating if sector sentiment sours. Macro risks include persistent inflation delaying Fed rate cuts, which could keep pressure on longer-duration, profitable-but-slower-growth tech stocks.
Worst-Case Scenario: The worst-case scenario involves a continuation of the current narrative: growth decelerates further into the mid-teens, competitive losses mount, and operating margins fail to expand meaningfully. This could lead to a cascade of analyst downgrades and a full valuation re-rate towards a pure-play value multiple. In this adverse scenario, the stock could realistically retest and break its 52-week low of $31.64, representing a downside of approximately -24% from the current price of $41.42. A breach of that level could trigger a new leg down towards the $30 support zone, aligning with a historical max drawdown that has already exceeded -42%.
FAQ
The key risks are, in order of severity: 1) Growth Deceleration Risk: The core investment narrative has soured due to guidance signaling slower future revenue growth, which could persist. 2) Competitive & Valuation Gap Risk: The market is favoring faster-growing competitors, creating a perception gap that may lead to continued underperformance. 3) Multiple Compression Risk: The trailing P/E of 67.6x remains elevated; any earnings miss could trigger further de-rating. 4) Execution Risk: The company must manage high operating expenses to expand its modest 7.8% net margin while investing for growth, a difficult balancing act.
The 12-month forecast is a range of scenarios. The Base Case (60% probability) sees the stock trading between $40 and $48 as growth stabilizes in the high-teens and the forward P/E holds around 18x. The Bull Case (25% probability) targets $50 to $57, requiring growth to re-accelerate and margins to expand, leading to a valuation re-rating. The Bear Case (15% probability) projects a drop to $31-$36 if growth decelerates further, breaking the 52-week low. The most likely scenario is the Base Case, which assumes the company executes on its current guidance and the valuation multiple stabilizes at current levels.
DT is in a transition from overvalued to fairly valued. Its trailing P/E of 67.6x is still high, but the more relevant forward P/E of 18.3x is reasonable for a profitable software company. Compared to its own history, where it traded above 90x, it is undervalued. Compared to the market's current preference for faster-growing peers, it may still be relatively overvalued. The valuation implies the market expects solid earnings growth (forward EPS estimate of ~$2.98) but has significantly dialed back expectations for revenue expansion. On a sum-of-the-parts basis—profitable growth plus a pristine balance sheet—the stock appears fairly valued to slightly undervalued after its steep decline.
DT is a conditional buy for specific investor profiles. For investors seeking hyper-growth, it is not a good buy, as growth is decelerating. For value-oriented investors comfortable with 'show me' stories, the current price offers a reasonable entry point into a company with exceptional profitability (81.4% gross margin) and strong free cash flow ($465.7M). The forward P/E of 18.3x is not excessive, but the key risk is further growth disappointment, which could send the stock back towards its 52-week low of $31.64. It is a good buy only for those who believe the growth slowdown is temporary and that the market will eventually reward its cash generation.
DT is more suitable for a medium-to-long-term investment horizon (2+ years). Its low beta of 0.74 and lack of dividend make it a poor short-term trading vehicle, as it lacks volatility and income. The investment thesis revolves around the market eventually recognizing the value of its durable profitability and cash flow, which is a narrative that may take multiple quarters to unfold. Given the current 'show me' phase and growth transition, investors need patience. A short-term trader would be better served by more volatile, catalyst-driven names. The suggested minimum holding period is 12-18 months to allow for the next few earnings cycles to clarify the growth trajectory.